Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Clavel

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
HIV Clinical Trials|January 31, 2002
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patientsP Clevenbergh, E Cua, E Dam, et al.
Princess Takamatsu Symposia|January 1, 1984
Lymphadenopathy associated virus and its etiological role in AIDSL Montagnier, J C Chermann, F Barré-Sinoussi, et al.
Science (New York, N.Y.)|July 18, 1986
Isolation of a new human retrovirus from West African patients with AIDSF Clavel, D Guétard, F Brun-Vézinet, et al.
AIDS Research and Human Retroviruses|May 15, 2001
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissuesM L Penn, M Myers, D A Eckstein, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 18, 1998
E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidémiologique auprès de femmes de l'Education NationaleF Clavel-Chapelon, M J van Liere, C Giubout, et al.
IARC Scientific Publications|December 18, 2002
Plasma concentrations of fatty acids in nine European countries: cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC)M Saadatian-Elahi, T Norat, H B Bueno-de-Mesquita, et al.
IARC Scientific Publications|December 18, 2002
Compliance with the urine marker PABAcheck in cancer epidemiology studiesS Runswick, B Slothouber, H Boeing, et al.
Public Health Nutrition|March 18, 2003
Food sources of carbohydrates in a European cohort of adultsE Wirfält, A McTaggart, V Pala, et al.
Public Health Nutrition|March 18, 2003
Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: data from 35 955 24-hour dietary recalls in 10 European countriesA Hjartåker, A Lagiou, N Slimani, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
HIV Clinical Trials|January 31, 2002
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patientsP Clevenbergh, E Cua, E Dam, et al.
Princess Takamatsu Symposia|January 1, 1984
Lymphadenopathy associated virus and its etiological role in AIDSL Montagnier, J C Chermann, F Barré-Sinoussi, et al.
Science (New York, N.Y.)|July 18, 1986
Isolation of a new human retrovirus from West African patients with AIDSF Clavel, D Guétard, F Brun-Vézinet, et al.
AIDS Research and Human Retroviruses|May 15, 2001
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissuesM L Penn, M Myers, D A Eckstein, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 18, 1998
E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidémiologique auprès de femmes de l'Education NationaleF Clavel-Chapelon, M J van Liere, C Giubout, et al.
IARC Scientific Publications|December 18, 2002
Plasma concentrations of fatty acids in nine European countries: cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC)M Saadatian-Elahi, T Norat, H B Bueno-de-Mesquita, et al.
IARC Scientific Publications|December 18, 2002
Compliance with the urine marker PABAcheck in cancer epidemiology studiesS Runswick, B Slothouber, H Boeing, et al.
Public Health Nutrition|March 18, 2003
Food sources of carbohydrates in a European cohort of adultsE Wirfält, A McTaggart, V Pala, et al.
Public Health Nutrition|March 18, 2003
Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: data from 35 955 24-hour dietary recalls in 10 European countriesA Hjartåker, A Lagiou, N Slimani, et al.
Pageof 21